Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay
NCT02586389 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2024-10-16
Summary
This specimen collection is designed to obtain whole blood and tumor tissue from subjects diagnosed with cancer for the purpose of the development of a noninvasive liquid biopsy assay using next generation sequencing (NGS).
Conditions
- Non-hematologic Cancer
Sponsors & Collaborators
-
Sequenom, Inc.
lead INDUSTRY
Principal Investigators
-
Sue Beruti, MD · Sequenom, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-13
- Primary Completion
- 2027-10-31
- Completion
- 2027-10-31
Countries
- United States
Study Locations
More Related Trials
-
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
NCT02682667 ·Status: RECRUITING
-
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
NCT00026884 ·Status: RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
NCT01441089 ·Status: RECRUITING
-
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
NCT05663502 ·Status: RECRUITING
-
Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers
NCT00580203 ·Status: COMPLETED
-
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
NCT03662204 ·Status: COMPLETED
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
NCT00899002 ·Status: WITHDRAWN
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
NCT00897117 ·Status: RECRUITING
-
Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers
NCT00899769 ·Status: COMPLETED
-
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
NCT05181826 ·Status: RECRUITING
-
Collection of Biological Specimens and Associated Health Information
NCT06369441 ·Status: NOT_YET_RECRUITING
-
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
NCT00898638 ·Status: RECRUITING
-
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
NCT03189108 ·Status: TERMINATED
-
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
NCT05530759 ·Status: RECRUITING
-
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
NCT02178163 ·Status: RECRUITING ·Phase: NA
-
Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit
NCT05360225 ·Status: COMPLETED
-
A Multicenter Cancer Biospecimen Collection Study
NCT04510129 ·Status: RECRUITING
-
Multi-analyte Blood Test Clinical Trial
NCT05199259 ·Status: RECRUITING
-
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
NCT00897767 ·Status: COMPLETED
-
Healthy Human Control Blood Collection for Validation of Biomarker Assay
NCT02302885 ·Status: COMPLETED
-
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
NCT00006518 ·Status: RECRUITING
-
HER-2 Mutations in Tumor Samples From Patients With Advanced Non-Small Cell Lung Cancer Treated on Clinical Trial ECOG-2598
NCT00896909 ·Status: COMPLETED
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202
NCT01503619 ·Status: COMPLETED
-
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
NCT00904514 ·Status: TERMINATED